A trial of void protocol is the planned removal of a urinary catheter to test whether the bladder can empty unaided: pull the catheter, prompt a void, then measure the post-void residual against a threshold set in advance. Also called a voiding trial or a trial without catheter, it is a removal decision with a pass number, not a checklist event.
Dr. Maya Olsson cleared a 48-year-old for discharge on a Tuesday morning after an apical prolapse repair. The ward nurse logged a voided 230 mL, the chart said the patient had passed, everyone signed. Nobody scanned. The patient came back through the emergency department at hour 30 in florid retention with a bladder holding 780 mL, the over-distension ceiling blown past by almost 200 mL. No one had been careless. They had followed the laminated toolkit taped to the bladder-scanner cart, the one that prints 300 mL acceptable next to 600 mL maximum capacity next to 600 to 800 mL repeat, and never once states the rule that turns those numbers into a decision.
That gap, between a voided volume and a passed trial, is the whole problem.
The rule this article exists to deliver: A void is not a pass. A pass is a void whose residual is low enough, captured deliberately enough, to trust the bladder unsupervised.
What a residual means in general, the age norms, the causes, the interpretation table, lives at /journal/post-void-residual, and how to capture one that is real lives at /journal/how-to-use-a-bladder-scanner. What follows is the decision the laminate omits: when to pull the catheter, which trial to run, what the number has to clear, and what to do when it does not, anchored to the Voiding leg of the IPC 4Is framework Dr. Di Wu works from at /journal/what-is-a-bladder-diary.
Why post-operative urinary retention happens, and who fails the trial
Post-operative urinary retention is the inability to void in the presence of a full bladder after surgery (Huang & Leslie, StatPearls 2026).
The mechanism is rarely the bladder itself. Anaesthetic and analgesic agents blunt the detrusor reflex, opioids suppress the urge, and anticholinergics plus a heavy intravenous fluid load stretch the bladder past the point where it can generate a contraction. Constipation and immobility finish the job. On a bladder already emptying against resistance, the surgery tips a marginal voider into frank retention.
The risk is not evenly spread, and knowing who carries it tells you whose trial to run with the most care. In the largest prospective real-world series, an international cohort of 4,151 patients after elective inguinal hernia repair, retention occurred in 5.8% of men, 2.97% of women, and 9.5% of men aged 65 or older, roughly one in eleven older men, and it was the single reason for more than half of all 30-day readmissions (Croghan et al, JAMA Surgery 2023).
A systematic review of 101,025 colorectal-surgery patients added the modifiable and the fixed predictors side by side: male sex, older age, diabetes, urological disease, low rectal tumours, operative time of 4 hours or more, excessive intraoperative fluid, later catheter removal, and post-operative ileus (Huang et al, International Journal of Colorectal Disease 2022).
And in a meta-analysis of 31,251 spine-surgery patients, the strongest single predictor was a pre-existing prostate, with benign prostatic hyperplasia carrying an odds ratio of 3.79, ahead of prior urinary tract infection, diabetes, and male sex, while same-day ambulation was protective (Chang et al, The Spine Journal 2021). Outlet obstruction is the thread running through all three. The article that proves obstruction rather than naming it sits at /journal/bladder-outlet-obstruction.
How to run a voiding trial: the removal trigger, the prompted void, and the check
Run the trial of void protocol as a sequence with a defined endpoint, not an open-ended wait. Remove the catheter, ensure the patient is hydrated enough to fill, give privacy and time to attempt a void, then measure the residual against a threshold you set before you started.
Time the attempt. A bladder needs volume to trigger a contraction, so the first void may take a few hours, but a patient who has not voided and reports no urge by 6 to 8 hours has declared the trial, and the move then is to scan and reassess rather than wait indefinitely. Measure the residual immediately after the void attempt, by bladder scan or in-and-out catheter. This article does not teach the scan: probe placement, preset, and the handful of ways the number lies are the entire subject of /journal/how-to-use-a-bladder-scanner. What matters here is that the residual is captured at once, before the kidneys refill the bladder and turn a real residual into an artefact.
The trial resolves into one of three states, and only one is a clean pass. A clean void with a low residual passes. No void, or a void trailing a high residual, fails and the catheter goes back. A middling result lands in an indeterminate zone that earns a recheck, not a verdict. The numbers that separate those states are the next section, and they are where the institutional toolkits contradict themselves.
Backfill or autofill: which method to run, and what the number buys you
There are two ways to run the trial, and the bedside toolkits almost never make you choose between them. An autofill or spontaneous trial removes the catheter and waits for the bladder to fill on its own. It is physiologic and needs no instrumentation, but it is slow and ties up a bed while you wait for diuresis. A backfill or retrograde-fill trial instils a known volume of saline through the catheter before removing it, usually 300 mL or until the patient reports urgency, so the clock starts with a bladder you know is full.
The backfill earns its place because it converts the trial into a measurement with published accuracy. In a validated algorithm derived from 255 women after urogynaecologic surgery, where the bladder was backfilled with 300 mL and the voided volume alone predicted success, a voided volume of 200 mL or more passed in 97% of cases while a voided volume under 100 mL failed in all but 3%, an ROC area of 0.97, and applying it would have eliminated the post-void residual measurement in 85% of patients (Meekins et al, Southern Medical Journal 2017).
The method also tolerates a simpler endpoint. A noninferiority trial in 174 women after apical prolapse repair compared a standard backfill, defined as voiding two-thirds of the instilled volume, against a subjective force-of-stream judgment, and found discharge failure rates of 26.4% and 17.4% respectively, with later catheterization needed in only about 3% of those who passed either way (Pilkinton et al, Obstetrics and Gynecology 2019). The lesson is not that one method wins universally. It is that a backfill trial with a pre-declared voided-volume cutoff gives you a defensible answer faster than waiting for an autofill and guessing.
Pass, indeterminate, or fail: the thresholds that end the trial
Here is the rule the laminate omits, and it uses only the cutoffs that end the trial, not the general residual table. A voided volume of 200 mL or more with a post-void residual under 100 mL, or under half of the total bladder volume, passes. A residual in the 100 to 199 mL band is indeterminate and earns a repeat scan or a second void rather than a catheter.
The total bladder volume, voided plus residual, should stay under the over-distension ceiling commonly cited between 400 and 600 mL, though a patient's own maximum capacity is a better guide than a fixed number, because a severely over-distended bladder can sustain temporary or even permanent lower-urinary-tract injury and lose the detrusor contractility it then needs time to recover (Brouwer et al, Perioperative Medicine 2021).
Two cautions keep this rule honest. The 100 mL residual cutoff is the threshold that ends this trial, not a statement about what counts as a normal residual in clinic, which is age-dependent and a different conversation entirely at /journal/post-void-residual. And a single residual is a sample, not a verdict: the toolkits that ask for the residual over three consecutive voids are right that one good void after catheter removal is weaker evidence than three. Set the threshold before the catheter comes out, document the post-void interval and the method beside the number, and the trial becomes a decision you can defend.
The failed trial: re-catheterize or teach self-catheterization
A failed trial is a fork, not a setback. The two arms are re-catheterization with an indwelling catheter and teaching clean intermittent self-catheterization, and the choice turns on how long you expect the retention to last and how able the patient is to manage a catheter at home. An indwelling catheter is simpler in the moment and worse over time, carrying the infection and bladder-neck burden of a continuous drain. Intermittent catheterization mimics the normal fill-and-empty cycle and spares the patient a bag, at the cost of teaching and manual dexterity. Time the next attempt to the residual: a modest residual earns a repeat in a day or two, a large one earns a longer interval and a lower threshold for involving urology.
The reassurance is evidence-based, and it is worth saying out loud to a discouraged patient. In a secondary analysis of the TOMUS mid-urethral-sling trial, 24% of women needed a repeat voiding trial after failing the first, yet at one year their objective success was actually higher than the women who passed immediately, 85.8% against 75.3% (Ferrante et al, Neurourology and Urodynamics 2014).
Failing the first trial predicts nothing bad about the eventual outcome. When the failure does not resolve and the bladder turns out to be a chronic non-emptier rather than a temporarily stunned one, that is a different diagnosis with a different workup, and it lives at /journal/underactive-bladder.
Raising the odds before a trial without catheter: alpha-blockers and opioid sparing
The toolkits describe how to run the trial but say almost nothing about how to make it succeed, and the levers are real. The clearest sits in benign prostatic obstruction. A Cochrane review of men trialled without a catheter after an episode of acute urinary retention found that 60.2% voided successfully on an alpha-blocker against 38.1% on placebo, with recurrent retention also lower, and the effect held for alfuzosin, tamsulosin, and silodosin but not doxazosin (Fisher et al, Cochrane Database of Systematic Reviews 2014).
A network meta-analysis ranked the combination of alfuzosin and tamsulosin ahead of either alone for catheter-free success (Gwon et al, Prostate International 2023).
In the broader surgical population the evidence is real but softer and worth presenting honestly rather than overselling. A meta-analysis of 23 randomized trials found peri-operative tamsulosin roughly halved the risk of retention (Baysden et al, American Journal of Health-System Pharmacy 2023), and a second meta-analysis localized that benefit to abdominal and female pelvic surgery, with no effect after spinal or limb surgery and better results when dosing continued post-operatively rather than a single pre-operative dose (Gao et al, Naunyn-Schmiedeberg's Archives of Pharmacology 2023).
The counterweight matters: a rigorous double-blind trial in abdominal surgery found no difference at all (Papageorge et al, Journal of Surgical Research 2021), and a 2025 trial of single-dose tamsulosin before a mid-urethral sling was likewise negative (Leffelman et al, International Urogynecology Journal 2025). Read together, the prophylactic alpha-blocker is a defensible move in the higher-risk male and pelvic-surgery patient, dosed through the post-operative window, and not a reflex for everyone.
The unglamorous levers do more than any drug. Minimize opioids, avoid over-resuscitating with intravenous fluid, and treat the constipation. At the bedside, a nurse-driven bundle of the sound of running water, warm fluid poured over the perineum, a hot caffeinated drink, and early ambulation prompted spontaneous voiding in about 45% of patients with post-operative voiding difficulty in one study, sparing them a catheter (Kolodziej et al, Advances in Clinical and Experimental Medicine 2023). Privacy, an upright position on a toilet rather than a bedpan, and adequate time are standard practice alongside them.
Surgery by surgery: where retention hides and when to trial
What earns its place in a clinician's head is knowing which operation produces which retention risk: it sets how carefully you run the trial and how readily you leave a catheter in.
After inguinal hernia repair, retention runs near 6% overall but climbs toward 1 in 10 in older men, and it drives the majority of 30-day readmissions, so the older male hernia patient is the one to scan rather than assume (Croghan et al, JAMA Surgery 2023). After pelvic and urogynaecologic surgery, baseline retention is strikingly high, near 49% in one outpatient prolapse series, and the predictors there were age under 55, diabetes, and a higher-stage cystocele rather than the anaesthetic, which means a backfill trial before discharge is close to mandatory (Alas et al, International Urogynecology Journal 2019).
After spine surgery, a pre-existing prostate is the dominant signal and early ambulation is protective (Chang et al, The Spine Journal 2021). After colorectal surgery, operative time, fluid load, and post-operative ileus drive the risk (Huang et al, International Journal of Colorectal Disease 2022).
The special case is the trial without catheter after an episode of acute urinary retention in benign prostatic hyperplasia, because here you can predict the result before you start. Even men already on medical therapy pass only about half the time, and the anatomy calls it: an intravesical prostatic protrusion under 10 mm predicted success with an odds ratio of 6.10, while a protrusion over 10 mm predicted failure (De Nunzio et al, Minerva Urology and Nephrology 2021; Tiong et al, Urologia Internationalis 2009). Why a protrusion obstructs flow at all is the work of the clinical pillar at /journal/bladder-outlet-obstruction; here it is just the predictor that calls the trial.
In the higher-risk patient, consider starting the alpha-blocker, look at the protrusion, and set expectations accordingly. The coding question that often rides along with these cases, the ICD-10 for retention, is handled at /journal/bladder-outlet-obstruction-icd-10.
Safety guardrails: the over-distension ceiling, autonomic dysreflexia, and the suprapubic variant
Three safety rules sit above the protocol and override it. The first is the over-distension ceiling already named: keep the total bladder volume under the 400 to 600 mL band, because a single severe stretch can injure the detrusor you are trying to rehabilitate. The second is specific and dangerous. In a patient with a spinal cord injury at or above the T6 level, a distending bladder can trigger autonomic dysreflexia, a life-threatening hypertensive episode, so a backfill that deliberately fills and distends the bladder demands autonomic-dysreflexia precautions and blood-pressure monitoring in these patients (Gondim et al, Current Vascular Pharmacology 2004).
The third is a method note: a suprapubic catheter can be trialled by clamping the catheter with a valve and assessing the urethral void, draining the suprapubic residual to read it, which is a cleaner trial than the urethral route because the catheter stays in place if the trial fails.
How to explain a trial of void to your patient
Patients hear "trial of void" as a test they can fail, so reframe it as a question the body answers. Tell them the catheter is coming out to see whether the bladder has woken up after surgery, and that the first urge may take a few hours. Afterward you will check with a quick scan or a brief catheter to confirm it emptied. Say plainly what passing and failing mean: passing means the catheter stays out, failing means it goes back in for a short while and they try again, and a failed first attempt is common and changes nothing about the eventual recovery. If a patient who passed the trial still feels they have not finished or dribbles afterward, that terminal sensation has its own explanation and management at /journal/post-micturition-dribbling.
Frequently asked questions
How do you perform a voiding trial?
Remove the catheter, make sure the bladder has volume to work with, give the patient privacy and time to attempt a void, then measure the post-void residual by bladder scan or in-and-out catheter. In a backfill trial the bladder is first filled with about 300 mL of saline so the attempt starts with a known volume. Compare the voided volume and the residual against a threshold set before the catheter came out.
How many hours does a voiding trial take?
The first void may take a few hours because the bladder needs to fill enough to trigger a contraction. A practical endpoint is 6 to 8 hours: a patient who has not voided and reports no urge by then has effectively declared the trial, and the next step is to scan and reassess rather than wait open-endedly.
How much urine counts as passing a voiding trial?
By a validated backfill rule, a voided volume of 200 mL or more with a residual under 100 mL, or under half the total bladder volume, passes; under 100 mL voided fails; 100 to 199 mL is an indeterminate zone that earns a recheck rather than a verdict (Meekins et al, Southern Medical Journal 2017).
Does a failed trial of void mean permanent retention?
No. Most post-operative retention is transient, and failing the first trial does not predict a worse outcome. Women who needed a repeat trial after sling surgery had higher long-term success than those who passed immediately (Ferrante et al, Neurourology and Urodynamics 2014). A failed trial means the catheter goes back briefly and you try again.
How do you wake the bladder up after surgery?
Minimize opioids, avoid over-loading with intravenous fluid, and treat constipation. At the bedside, give privacy, sit the patient upright on a toilet rather than a bedpan, allow time, run water within earshot, pour warm fluid over the perineum, and walk first if the operation allows. In men with a prostate, a peri-operative alpha-blocker raises the odds of voiding (Fisher et al, Cochrane Database of Systematic Reviews 2014).
Open the bladder diary calculator: bladderdiaries.com/entry
Two ways in: upload a digital diary PDF (from myflowcheck.com or any structured export), or enter the data manually. The calculator returns 24-hour voided volume, maximum voided volume, average voided volume, and the IPC 4Is mapping in seconds, the shared layer that puts a single trial-of-void residual in context across the whole voiding pattern.
Pull the catheter on a rule, not a reflex
Dr. Olsson's patient did not bounce back because anyone was careless. She bounced back because a voided number was mistaken for a passed trial, and the toolkit on the cart never supplied the rule that would have caught it. The trial of void protocol is a small rule, and it is the whole job: set the pass threshold before the catheter comes out, choose the trial method on purpose, scan the residual immediately, respect the over-distension ceiling, and read the result as pass, indeterminate, or fail rather than void or no-void. The trial sits on the Voiding leg of the 4Is for a reason, because emptying is the question it answers, and the framework that puts it in context starts at /journal/what-is-a-bladder-diary.
Author: Dr. Di Wu, MD, PT (IPC founding member). Medically reviewed by Dr. Steven Tijerina, PT, DPT, Cert. MDT (IPC US Director). Photo: Gabriel McCallin on Unsplash.
